Relievant Medsystems Obtains $30,000,000 Series D Financing Round

  • Feed Type
  • Date
    3/28/2012
  • Company Name
    Relievant Medsystems
  • Mailing Address
    2688 Middlefield Road Redwood City, CA 94063
  • Company Description
    Relievant MedSystems is a medical device company developing novel products to treat lower back pain using a minimally invasive therapeutic approach. The company was founded in 2004 and is headquartered in San Francisco, California.
  • Website
    http://www.relievant.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $30,000,000
  • Transaction Round
    Series D
  • Proceeds Purposes
    Proceeds from this financing will enable Relievant to accelerate execution of our landmark SMART Clinical Trial and to conduct additional clinical studies for the Intracept Ablation System. These studies are key drivers for our plan to continue advancing the utility of basivertebral nerve ablation for isolated axial low back pain and to successfully commercialize Intracept worldwide.
  • M&A Terms
  • Venture Investor
    New Enterprise Associates
  • Venture Investor
    Canaan Partners
  • Venture Investor
    Emergent Medical Partners
  • Venture Investor
    Morgenthaler Ventures
  • Venture Investor
    ONSET Ventures

By posting a comment, you agree to our terms and conditions.